title: Response to: Does the Nerium oleander extract PBI-05204 have potential for pancreatic cancer?
authors.affiliation: Department of Experimental Therapeutics, University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA, rnewman@phoenixbiotechnology.com.
authors.forename: Robert A
authors.initials: RA
authors.lastname: Newman
authors.forename: Peiying
authors.initials: P
authors.lastname: Yang
mesh_terms: D000818:Animals; D002301:Cardiac Glycosides / Q000494:pharmacology*; D058544:Class Ib Phosphatidylinositol 3-Kinase / Q000096:biosynthesis*; D005260:Female; D006801:Humans; D030007:Nerium; D010190:Pancreatic Neoplasms / Q000188:drug therapy*; D010936:Plant Extracts / Q000494:pharmacology*; D058570:TOR Serine-Threonine Kinases / Q000096:biosynthesis*
chemical_list: D002301:Cardiac Glycosides; D010936:Plant Extracts; D058544:Class Ib Phosphatidylinositol 3-Kinase; D058570:TOR Serine-Threonine Kinases